Feasibility, toxicity and response of upfront metaiodobenzylguanidine therapy therapy followed by German Pediatric Oncology Group Neuroblastoma 2004 protocol in newly diagnosed stage 4 neuroblastoma patients

K Kraal; GM Bleeker; BLF Eck-Smit; Natasha van Eijkelenburg; F Berthold; MM Noesel; HN Caron; GAM Tytgat

doi:10.1016/j.ejca.2016.12.013

Feasibility, toxicity and response of upfront metaiodobenzylguanidine therapy therapy followed by German Pediatric Oncology Group Neuroblastoma 2004 protocol in newly diagnosed stage 4 neuroblastoma patients

K Kraal, GM Bleeker, BLF Eck-Smit, Natasha van Eijkelenburg, F Berthold, MM Noesel, HN Caron, GAM Tytgat

Pediatrics

Research output: Contribution to journal › Article › Academic › peer-review

23 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	188-196
Number of pages	9
Journal	European Journal of Cancer
Volume	76
DOIs	https://doi.org/10.1016/j.ejca.2016.12.013
Publication status	Published - 2017

Access to Document

10.1016/j.ejca.2016.12.013

http://hdl.handle.net/1765/108030

Cite this

Kraal, K., Bleeker, GM., Eck-Smit, BLF., van Eijkelenburg, N., Berthold, F., Noesel, MM., Caron, HN., & Tytgat, GAM. (2017). Feasibility, toxicity and response of upfront metaiodobenzylguanidine therapy therapy followed by German Pediatric Oncology Group Neuroblastoma 2004 protocol in newly diagnosed stage 4 neuroblastoma patients. European Journal of Cancer, 76, 188-196. https://doi.org/10.1016/j.ejca.2016.12.013

@article{0bb95900052c4087a2920b645093a866,

title = "Feasibility, toxicity and response of upfront metaiodobenzylguanidine therapy therapy followed by German Pediatric Oncology Group Neuroblastoma 2004 protocol in newly diagnosed stage 4 neuroblastoma patients",

author = "K Kraal and GM Bleeker and BLF Eck-Smit and {van Eijkelenburg}, Natasha and F Berthold and MM Noesel and HN Caron and GAM Tytgat",

year = "2017",

doi = "10.1016/j.ejca.2016.12.013",

language = "Undefined/Unknown",

volume = "76",

pages = "188--196",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

Kraal, K, Bleeker, GM, Eck-Smit, BLF, van Eijkelenburg, N, Berthold, F, Noesel, MM, Caron, HN & Tytgat, GAM 2017, 'Feasibility, toxicity and response of upfront metaiodobenzylguanidine therapy therapy followed by German Pediatric Oncology Group Neuroblastoma 2004 protocol in newly diagnosed stage 4 neuroblastoma patients', European Journal of Cancer, vol. 76, pp. 188-196. https://doi.org/10.1016/j.ejca.2016.12.013

Feasibility, toxicity and response of upfront metaiodobenzylguanidine therapy therapy followed by German Pediatric Oncology Group Neuroblastoma 2004 protocol in newly diagnosed stage 4 neuroblastoma patients. / Kraal, K; Bleeker, GM; Eck-Smit, BLF et al.
In: European Journal of Cancer, Vol. 76, 2017, p. 188-196.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Feasibility, toxicity and response of upfront metaiodobenzylguanidine therapy therapy followed by German Pediatric Oncology Group Neuroblastoma 2004 protocol in newly diagnosed stage 4 neuroblastoma patients

AU - Kraal, K

AU - Bleeker, GM

AU - Eck-Smit, BLF

AU - van Eijkelenburg, Natasha

AU - Berthold, F

AU - Noesel, MM

AU - Caron, HN

AU - Tytgat, GAM

PY - 2017

Y1 - 2017

U2 - 10.1016/j.ejca.2016.12.013

DO - 10.1016/j.ejca.2016.12.013

M3 - Article

SN - 0959-8049

VL - 76

SP - 188

EP - 196

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -